Your browser doesn't support javascript.
loading
Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.
Lempens, Pauline; Meehan, Conor J; Vandelannoote, Koen; Fissette, Kristina; de Rijk, Pim; Van Deun, Armand; Rigouts, Leen; de Jong, Bouke C.
Affiliation
  • Lempens P; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. plempens@itg.be.
  • Meehan CJ; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. plempens@itg.be.
  • Vandelannoote K; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Fissette K; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • de Rijk P; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Van Deun A; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Rigouts L; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • de Jong BC; Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Sci Rep ; 8(1): 3246, 2018 02 19.
Article de En | MEDLINE | ID: mdl-29459669

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oxidoreductases / Protéines bactériennes / Catalase / Résistance bactérienne aux médicaments / Isoniazide / Mutation / Mycobacterium tuberculosis / Antituberculeux Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Sci Rep Année: 2018 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oxidoreductases / Protéines bactériennes / Catalase / Résistance bactérienne aux médicaments / Isoniazide / Mutation / Mycobacterium tuberculosis / Antituberculeux Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Sci Rep Année: 2018 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni